Peripheral Neuropathy Trial, Recruiting NCT06844734 Sponsor: Shanghai 6th People's Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06844734
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with hereditary spastic paraplegia (HSP) based on both their symptoms and genetic testing
  • People between the ages of 14 and 70 years old
  • People who have significant muscle stiffness in the legs, specifically where at least 2 joints are rated at grade 3 or higher on a standard muscle tone scale (confirm with trial site)
  • People who are willing to take part and are able to understand and follow the study requirements

Who may not be able to join:

  • People who have a known allergy to the medication baclofen
  • People who have another neurological (brain or nerve) condition that could affect how the study results are measured
  • People who have had a serious health condition in the past year, such as heart disease, cancer, a blood disorder, liver disease, or kidney disease
  • Women who are pregnant or breastfeeding, or people who are unable to use a suitable form of contraception during the trial
  • People who are currently taking part in another clinical drug trial, or who have taken an experimental drug within the past 30 days
  • People who are unlikely to be able to follow the study requirements closely, or who have other factors the trial team considers unsuitable for participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Cao, phD, Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phone: +86 21 64369263

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai 6th People's Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Six-Minute Walk Test(6-MWT); Step length; walking speed; knee flexion angle; Modified Ashworth Scale(MAS); Range of Motion (ROM) of Joints

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov